Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

ALS Crowd Radio: Dr. Alfred Goldberg, PhD, Harvard Medical School

  • Broadcast in Health
ALS Crowd Radio

ALS Crowd Radio

×  

Follow This Show

If you liked this show, you should follow ALS Crowd Radio.
h:735459
s:8203447
archived
Play

Borrowing from one cancer treatment to treat another is common, but the insights learned from a cancer treatment class of drugs could be applied to neurological disorders like ALS. Dr. Alfred Goldberg, PhD of Harvard Medical School has deep expertise in proteasome inhibitors. These drugs are commonly used in blood cancers, but he has found a potential use for them in neurological disorders including ALS. 

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled